| NCT Number | NCT07063225 |
| Lead Sponsor | Institute of Hematology & Blood Diseases Hospital, China
Collaborators: Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University Second Hospital, Tianjin Third Central Hospital, Tianjin People's Hospital, Henan Cancer Hospital, The Second Affiliated Hospital of Kunming Medical University |
| Conditions | Chemotherapy-induced Thrombocytopenia, Romiplostim N01 |
| Enrollment | 50 participants |
| Start Date | 2025-08 |
| Primary Completion | 2026-08 (estimated) |
| Study Completion | 2026-08 (estimated) |
| Updated on ClinicalTrials.gov | 2025-07-14 |